Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 43Stomach Neoplasms 42Rectal Neoplasms 28Pancreatic Neoplasms 17Lymphoma, Large B-Cell, Diffuse 13Colonic Neoplasms 13Cholangiocarcinoma 11Neoplasm Metastasis 10Adenocarcinoma 10Neoplasms 9Carcinoma, Hepatocellular 8Carcinoma, Non-Small-Cell Lung 7Biliary Tract Neoplasms 7Locally Advanced Rectal Cancer 6Gastrointestinal Neoplasms 6Gallbladder Neoplasms 6Esophageal Neoplasms 6Adenocarcinoma Of Esophagus 6Peritoneal Neoplasms 5Recurrence 4Ovarian Neoplasms 4Esophageal Squamous Cell Carcinoma 3Carcinoma 3Bile Duct Neoplasms 3Appendiceal Neoplasms 3Advanced Solid Tumors 3Advanced Solid Tumor 3Pathologic Complete Response 2Melanoma 2Lymphoma, Non-Hodgkin 2

Interventions

bismuth tripotassium dicitrate 1S 1 (combination) 1Palliative Care 1Oxaliplatin 1Omeprazole 1Clarithromycin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Chemotherapy Effect × Oxaliplatin × Clear all
NCT06510010 2026-01-26

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Recruiting
198 enrolled

Chemotherapy Effect

Data powered by HemOnc (CC BY 4.0) Colophon âš¡